PMDA drug package insert
メマリー錠5mg
PMDA Prescription drug · 第一三共株式会社 · package insert Jun 16, 2020
Key facts
| Brand names | メマリー錠5mg, メマリー錠10mg, メマリー錠20mg, メマリーOD錠5mg, メマリーOD錠10mg, メマリーOD錠20mg |
|---|---|
| Nonproprietary names | メマンチン塩酸塩 |
| Companies | 製造販売元／第一三共株式会社, 提携／メルツ ファーマシューティカルズ |
| Product type | Prescription drug |
| Therapeutic category | NMDA受容体拮抗 アルツハイマー型認知症治療剤 |
| Therapeutic category codes | 87119 |
| YJ codes | 1190018F1023, 1190018F2020, 1190018F3026, 1190018F4022, 1190018F5029, 1190018F6025 |
| Approval numbers | 22300AMX00423, 22300AMX00424, 22300AMX00425, 22500AMX01942, 22500AMX01943, 22500AMX01944 |
| Package insert edition | 第2版 |
| Package insert date | Jun 16, 2020 |
| PMDA document key | 430574_1190018F1023_1 |
| PMDA company code | 430574 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: